Filgrastim, Cladribine, Cytarabine, and Mitoxantrone With Sorafenib in Treating Patients With Newly-Diagnosed, Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

NCT02728050 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Acute Biphenotypic Leukemia
Acute Myeloid Leukemia
de Novo Myelodysplastic Syndrome
Myelodysplastic Syndrome
Myeloproliferative Neoplasm

Interventions

DRUG: Cladribine
DRUG: Cytarabine
BIOLOGICAL: Filgrastim
OTHER: Laboratory Biomarker Analysis
OTHER: Quality-of-Life Assessment
DRUG: Mitoxantrone
DRUG: Sorafenib

Sponsor

University of Washington

Collaborators

[object Object]
[object Object]